Kiran Konain, Jieun Bae, Mariam Amir, Sajida Farid, Aiman Saeed, Muhammad Tahir Sarwar, Kyung Mi Woo, Saeed Ur Rahman
{"title":"Biofunctionalized nanofibrous scaffolds for enhancing osteoblast cells proliferation.","authors":"Kiran Konain, Jieun Bae, Mariam Amir, Sajida Farid, Aiman Saeed, Muhammad Tahir Sarwar, Kyung Mi Woo, Saeed Ur Rahman","doi":"10.1177/09592989261489547","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundBiomimetic nanofibrous scaffolds have shown promising potential in tissue engineering as a means for local drug delivery of osteoinductive small molecules and recapitulating the nanotopograpy of the extracellular matrix (ECM).ObjectiveThe current study aims at construction a cytocompatible, biodegradable, drug loaded nanofibrous scaffold to enhance osteoblast cell proliferation.MethodsHerein, we synthesized berberine (BrB)-incorporated poly(ε-caprolactone) (PCL) nanofibrous scaffold via electrospinning, and various cellular and physicochemical characterization studies were performed using MC3T3-E1 osteoblasts to determine cytocompatibility.ResultsThe results demonstrate that BrB exhibits a hormetic effect with optimal dose at 10 µg indicating an increase in osteoblast cell proliferation. Scanning electron microscopy (SEM) analysis revealed uniform, randomly aligned, beadless fibers, with greater proportion of fibers in lower nano-range with the addition of BrB. Energy-dispersive X-ray (EDX) spectroscopy confirmed the elemental composition consistent with PCL and the successful incorporation of BrB. X-ray diffraction (XRD) demonstrated preserved crystallinity of the PCL nanofibers, while Fourier transform infrared (FTIR) spectroscopy verified characteristic functional groups of BrB within the PCL matrix, substantiating its molecular integration. The scaffold exhibited controlled degradation and sustained drug release profiles with improved swelling capacity, which is favorable for tissue regeneration. Notably, PCL-BrB demonstrated biocompatibility and enhanced osteoblast cells adhesion and proliferation.ConclusionCollectively, these findings validate the BrB-loaded PCL nanofibrous scaffold as a promising biomaterial platform for guiding osteoblast cells proliferation.</p>","PeriodicalId":9109,"journal":{"name":"Bio-medical materials and engineering","volume":" ","pages":"9592989261489547"},"PeriodicalIF":1.3000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bio-medical materials and engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/09592989261489547","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundBiomimetic nanofibrous scaffolds have shown promising potential in tissue engineering as a means for local drug delivery of osteoinductive small molecules and recapitulating the nanotopograpy of the extracellular matrix (ECM).ObjectiveThe current study aims at construction a cytocompatible, biodegradable, drug loaded nanofibrous scaffold to enhance osteoblast cell proliferation.MethodsHerein, we synthesized berberine (BrB)-incorporated poly(ε-caprolactone) (PCL) nanofibrous scaffold via electrospinning, and various cellular and physicochemical characterization studies were performed using MC3T3-E1 osteoblasts to determine cytocompatibility.ResultsThe results demonstrate that BrB exhibits a hormetic effect with optimal dose at 10 µg indicating an increase in osteoblast cell proliferation. Scanning electron microscopy (SEM) analysis revealed uniform, randomly aligned, beadless fibers, with greater proportion of fibers in lower nano-range with the addition of BrB. Energy-dispersive X-ray (EDX) spectroscopy confirmed the elemental composition consistent with PCL and the successful incorporation of BrB. X-ray diffraction (XRD) demonstrated preserved crystallinity of the PCL nanofibers, while Fourier transform infrared (FTIR) spectroscopy verified characteristic functional groups of BrB within the PCL matrix, substantiating its molecular integration. The scaffold exhibited controlled degradation and sustained drug release profiles with improved swelling capacity, which is favorable for tissue regeneration. Notably, PCL-BrB demonstrated biocompatibility and enhanced osteoblast cells adhesion and proliferation.ConclusionCollectively, these findings validate the BrB-loaded PCL nanofibrous scaffold as a promising biomaterial platform for guiding osteoblast cells proliferation.
期刊介绍:
The aim of Bio-Medical Materials and Engineering is to promote the welfare of humans and to help them keep healthy. This international journal is an interdisciplinary journal that publishes original research papers, review articles and brief notes on materials and engineering for biological and medical systems. Articles in this peer-reviewed journal cover a wide range of topics, including, but not limited to: Engineering as applied to improving diagnosis, therapy, and prevention of disease and injury, and better substitutes for damaged or disabled human organs; Studies of biomaterial interactions with the human body, bio-compatibility, interfacial and interaction problems; Biomechanical behavior under biological and/or medical conditions; Mechanical and biological properties of membrane biomaterials; Cellular and tissue engineering, physiological, biophysical, biochemical bioengineering aspects; Implant failure fields and degradation of implants. Biomimetics engineering and materials including system analysis as supporter for aged people and as rehabilitation; Bioengineering and materials technology as applied to the decontamination against environmental problems; Biosensors, bioreactors, bioprocess instrumentation and control system; Application to food engineering; Standardization problems on biomaterials and related products; Assessment of reliability and safety of biomedical materials and man-machine systems; and Product liability of biomaterials and related products.